Supreme Court preserves mail access for abortion pill
The Supreme Court will continue to allow the abortion pill mifepristone to be distributed by mail, at least for now. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR and gene editing: The push for in…
The Supreme Court will continue to allow the abortion pill mifepristone to be distributed by mail, at least for now.
The Thursday ruling maintains mifepristone's current safety protocols while litigation over ...
Source: Endpoints News